Johnson SW - Search Results

1

The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel.

Mitsuuchi Y, Johnson SW, Selvakumaran M, Williams SJ, Hamilton TC, Testa JR. Mitsuuchi Y, et al. Among authors: johnson sw. Cancer Res. 2000 Oct 1;60(19):5390-4. Cancer Res. 2000. PMID: 11034077

2

Evidence for altered regulation of gamma-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines.

Yao KS, Godwin AK, Johnson SW, Ozols RF, O'Dwyer PJ, Hamilton TC. Yao KS, et al. Among authors: johnson sw. Cancer Res. 1995 Oct 1;55(19):4367-74. Cancer Res. 1995. PMID: 7671249

3

Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells.

Johnson SW, Swiggard PA, Handel LM, Brennan JM, Godwin AK, Ozols RF, Hamilton TC. Johnson SW, et al. Cancer Res. 1994 Nov 15;54(22):5911-6. Cancer Res. 1994. PMID: 7954422

4

Mechanisms of drug resistance in ovarian cancer.

Johnson SW, Ozols RF, Hamilton TC. Johnson SW, et al. Cancer. 1993 Jan 15;71(2 Suppl):644-9. doi: 10.1002/cncr.2820710224. Cancer. 1993. PMID: 8420689 Review.

5

Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines.

Johnson SW, Laub PB, Beesley JS, Ozols RF, Hamilton TC. Johnson SW, et al. Cancer Res. 1997 Mar 1;57(5):850-6. Cancer Res. 1997. PMID: 9041185

6

The chemopreventive agent oltipraz stimulates repair of damaged DNA.

O'Dwyer PJ, Johnson SW, Khater C, Krueger A, Matsumoto Y, Hamilton TC, Yao KS. O'Dwyer PJ, et al. Among authors: johnson sw. Cancer Res. 1997 Mar 15;57(6):1050-3. Cancer Res. 1997. PMID: 9067269

7

Molecular biology of gynecologic malignancies.

Hamilton TC, Johnson SW, Godwin AK. Hamilton TC, et al. Among authors: johnson sw. Cancer Treat Res. 1998;95:103-14. doi: 10.1007/978-1-4615-5447-9_2. Cancer Treat Res. 1998. PMID: 9619281 Review. No abstract available.

8

Translocation and activation of AKT2 in response to stimulation by insulin.

Mitsuuchi Y, Johnson SW, Moonblatt S, Testa JR. Mitsuuchi Y, et al. Among authors: johnson sw. J Cell Biochem. 1998 Sep 15;70(4):433-41. J Cell Biochem. 1998. PMID: 9712142

9

Evaluation of carboplatin pharmacokinetics in the absence and presence of paclitaxel.

Obasaju CK, Johnson SW, Rogatko A, Kilpatrick D, Brennan JM, Hamilton TC, Ozols RF, O'Dwyer PJ, Gallo JM. Obasaju CK, et al. Among authors: johnson sw. Clin Cancer Res. 1996 Mar;2(3):549-52. Clin Cancer Res. 1996. PMID: 9816202 Clinical Trial.

10

Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2.

Mitsuuchi Y, Johnson SW, Sonoda G, Tanno S, Golemis EA, Testa JR. Mitsuuchi Y, et al. Among authors: johnson sw. Oncogene. 1999 Sep 2;18(35):4891-8. doi: 10.1038/sj.onc.1203080. Oncogene. 1999. PMID: 10490823

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters